Indian Journal of Urology Users online:2414  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis
Nikolay I. Nikolov,Vladislav R. Dunev,Angel A. Anatoliev,Nikolay H. Kolev,Martin B. Stoykov,Boyan S. Atanasov
Journal of Biomedical and Clinical Research.2022;15(1)70
[DOI]
2Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma
Clayton J. Bell,Kyle G. Potts,Mary M. Hitt,Desmond Pink,Jack A. Tuszynski,John D. Lewis
Cancer Letters.2022;526(1)168
[DOI]
3Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
Mohamad Moussa,Athanasios G Papatsoris,Athanasios Dellis,Mohamed Abou Chakra,Wajih Saad
Expert Review of Anticancer Therapy.2020;20(11)965
[DOI]
4Low Releasing Mitomycin C Molecule Encapsulated with Chitosan Nanoparticles for Intravesical Installation
Doga Kavaz,Feyza Kirac,Mustafa Kirac,Ashok Vaseashta
Journal of Biomaterials and Nanobiotechnology.2017;08(04)203
[DOI]
5Acute Pericarditis Occurring Three Days after Intravesical Instillation of Mitomycin C after Transurethral Bladder Tumor Resection in a 64-Year-Old Woman
Vineet Meghrajani,Arsalan Hashmi,Shuo Cheng Lin,Zvi Plawes,Shelly Brejt
Case Reports in Cardiology.2018;2018(04)1
[DOI]
6RRM1 predicts clinical outcome of high-and intermediate-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine monotherapy
Zhenxing Yang,Bingqiang Fu,Luqiang Zhou,Jie Xu,Ping Hao,Zhenqiang Fang
BMC Urology.2019;19(1)1
[DOI]
7Intravesical electromotive drug administration for non-muscle invasive bladder cancer
Jae Hung Jung,Ahmet Gudeloglu,Halil Kiziloz,Gretchen M Kuntz,Alea Miller,Badrinath R Konety,Philipp Dahm
Cochrane Database of Systematic Reviews.2017;2017(9)1
[DOI]
8Intravesical electromotive drug administration for non-muscle invasive bladder cancer
Jae Heon Kim
Cochrane Database of Systematic Reviews.2018;2017(9)241
[DOI]
9Hope and challenge: Precision medicine in bladder cancer
Hongwei Su,Haitao Jiang,Tao Tao,Xing Kang,Xu Zhang,Danyue Kang,Shucheng Li,Chengxi Li,Haifeng Wang,Zhao Yang,Jinku Zhang,Chong Li
Cancer Medicine.2019;8(4)1806
[DOI]
10Squamous differentiation in pT1 bladder urothelial carcinoma predicts poor response for intravesical chemotherapy
Gang Li,Jieping Hu,Yuanjie Niu
Oncotarget.2018;9(1)217
[DOI]
11Monoclonal antibody Zt/g4 targeting RON receptor tyrosine kinase enhances chemosensitivity of bladder cancer cells to Epirubicin by promoting G1/S arrest and apoptosis
Jun-Feng Chen,Bi-Xia Yu,Rui Yu,Liang Ma,Xiu-Yi Lv,Yue Cheng,Qi Ma
Oncology Reports.2017;37(2)721
[DOI]
12Autophagy and urothelial carcinoma of the bladder: A review
Thenappan Chandrasekar,Christopher P. Evans
Investigative and Clinical Urology.2016;57(Suppl 1)S89
[DOI]
13Synthesis, Characterization, and Biological Activity of Anthraquinone-Substituted Imidazolium Salts for the Treatment of Bladder Cancer
Michael L. Stromyer,David J. Weader,Uttam Satyal,Philip H. Abbosh,Wiley J. Youngs
Bladder Cancer.2020;6(4)471
[DOI]
14Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics
Jan P. Bogen,Julius Grzeschik,Joern Jakobsen,Alexandra Bähre,Björn Hock,Harald Kolmar
Frontiers in Oncology.2021;11(4)471
[DOI]
15Formulation and characterization of EGCG for the treatment of superficial bladder cancer
Katarzyna Dettlaff,Maciej Stawny,Magdalena Ogrodowczyk,Anna Jelinska,Waldemar Bednarski,Dorota Watróbska-Swietlikowska,Rick W. Keck,Omar A. Khan,Ibrahim H. Mostafa,Jerzy Jankun
International Journal of Molecular Medicine.2017;40(2)329
[DOI]
16Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin
Susanne Deininger,Peter Törzsök,David Oswald,Lukas Lusuardi
Cancers.2021;13(13)3206
[DOI]
17Advances in risk stratification of bladder cancer to guide personalized medicine
Justin T. Matulay,Ashish M. Kamat
F1000Research.2018;7(13)1137
[DOI]
18The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro
Tatjana Harting,Mandy Stubbendorff,Saskia Willenbrock,Siegfried Wagner,Patrik Schadzek,Anaclet Ngezahayo,Hugo Murua Escobar,Ingo Nolte
International Journal of Oncology.2016;49(6)2341
[DOI]
19Efficacy of Bladder Intravesical Chemotherapy with Three Drugs for Preventing Non-Muscle-Invasive Bladder Cancer Recurrence
Jianglei Zhang,Miao Li,Ze Chen,Jun OuYang,Zhixin Ling,Le Sun
Journal of Healthcare Engineering.2021;2021(6)1
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us